|
⚲
|
| Keyboard |
| Eckhardt Sue Gail
✚
|
|
|---|---|
| CIK # | 0001823769 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001823769] | |
| 4 | [0001823769] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Eckhardt Sue Gail | |
| Exelixis Inc | |
| Syros Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Exelixis Inc EXEL
Common Stock
|
2026-02-13 | Sell | 3,856 | $43.79 | 168,854 |
|
Exelixis Inc EXEL
Common Stock
|
2025-06-02 | Sell | 4 | $43.67 | 175 |
|
Exelixis Inc EXEL
Common Stock
|
2025-06-02 | Sell | 18,834 | $42.74 | 804,965 |
|
Exelixis Inc EXEL
Common Stock
|
2025-05-29 | Grant | 9,812 | $0.00 | |
|
Exelixis Inc EXEL
Common Stock
|
2025-02-14 | Sell | 7,712 | $35.01 | 269,997 |
|
Exelixis Inc EXEL
Common Stock
|
2025-02-14 | Sell | 3,856 | $35.04 | 135,114 |
|
Exelixis Inc EXEL
Common Stock
|
2025-02-14 | Option exercise | 7,712 | $23.24 | 179,227 |
|
Exelixis Inc EXEL
Option (right to buy) · derivative
|
2025-02-14 | Option exercise | 7,712 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-06-05 | Grant | 4,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Stock Option (right to buy) · derivative
|
2024-06-05 | Grant | 6,000 | $0.00 | |
|
Exelixis Inc EXEL
Common Stock
|
2024-05-31 | Grant | 18,838 | $0.00 | |
|
Exelixis Inc EXEL
Common Stock
|
2024-01-05 | Grant | 15,424 | $0.00 | |
|
Exelixis Inc EXEL
Option (right to buy) · derivative
|
2024-01-05 | Grant | 30,848 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2023-06-01 | Grant | 4,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Stock Option (right to buy) · derivative
|
2023-06-01 | Grant | 6,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2022-09-16 | Grant | 8,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Stock Option (right to buy) · derivative
|
2022-09-16 | Grant | 12,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Stock Option (right to buy) · derivative
|
2022-06-01 | Grant | 17,500 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Stock Option (right to buy) · derivative
|
2021-06-08 | Grant | 17,500 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Stock Option (right to buy) · derivative
|
2020-09-08 | Grant | 35,000 | $0.00 |